Preview

Russian Journal of Cardiology

Advanced search

Features of simple inflammation markers in assessing the plaque vulnerability in patients with acute coronary syndrome

https://doi.org/10.15829/1560-4071-2025-5850

EDN: CPLNDR

Abstract

Aim. To assess the relationship between simple inflammation markers and plaque vulnerability criteria according to coronary computed tomography angiography (CCTA), as well as lipid profile parameters in patients with acute coronary syndrome (ACS).

Material and methods. This prospective, randomized, single-center study included 125 patients admitted urgently with the clinical performance of ACS (myocardial infarction (MI) — 94 patients; unstable angina (UA) — 31). All patients underwent percutaneous coronary intervention of the infarct-related artery. In addition, all patients had atherosclerotic plaques with stenosis <50% in one or two non-infarct-related arteries. Treatment of ACS was carried out according to the guidelines. One month after ACS, all patients underwent CCTA to detect vulnerable plaques, as well as lipid profile analysis (total cholesterol (TC), lowdensity lipoprotein (LDL) cholesterol, triglycerides, high-density lipoprotein (HDL) cholesterol), simple inflammatory biomarkers C-reactive protein (CRP), neutrophilto-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-HDL-C ratio (MHR), lymphocyte-to-monocyte ratio (LMR), lymphocyte-to-CRP ratio (LCR).

Results. Of the 125 patients included in the study, MI was diagnosed in 94 (75%) patients, and UA in the remaining cases. In the acute period, in patients with MI, the HDL-C value was significantly lower 1,2 (1,03; 1,5) mmol/L than in the group of patients with UA (1,4 (1,24; 1,58) mmol/L), p=0,044. NLR was higher in patients with MI — 2,96 (2,09; 3,99) versus 2,21 (1,69; 2,71) in the UA group (p=0,018). One month after the index event, the HDL-C level remained significantly lower in the MI group 1,08 (0,95; 1,34) mmol/L, and the MHR was higher (0,52 (0,37; 0,64)) than in UA (1,25 (1,15; 1,34) mmol/L and 0,41 (0,31; 0,52)), respectively. The LCR after 1 month was almost 2 times higher in the UA group — 1,32 (0,65; 2,28) versus 0,66 (0,34; 1,28) in the MI group (p=0,028). The vulnerability criteria of plaques according to CCTA data were identified in 55 (44%) patients in the general group with ACS, of which positive remodeling was detected in 35 patients, a low-density area — in 30, and punctate calcifications (PC) — in 11. Patients in the general ACS group were divided by vulnerability criteria. Patients with PC had a significantly (p=0,004) higher level of HDL-C 1,22 (1,02; 1,34), compared to those without it 0,97 (0,77; 1,13). The MHR was higher (p=0,024) in the presence of PC (0,61 (0,48; 0,86)) than without it (0,46 (0,35; 0,63)). No significant differences were found for other indicators. When conducting the ROC analysis in patients with PC, the threshold level of HDL-C was 0,98 (AUC: 0,76, Sensitivity 66,7%, Specificity 77,4%), the threshold level of HDL-C in the presence of low-density area simultaneously with PC was also 0,98 (AUC: 0,83, Sensitivity 75%, Specificity 75,7%).

Conclusion. The HDL-C and MHR indicators significantly changed in patients who had ACS and microcalcifications in the plaques.

About the Authors

A. N. Kovalskaya
Samara State Medical University
Russian Federation

Samara


Competing Interests:

None



G. R. Bikbaeva
Polyakov Samara Regional Clinical Cardiology Dispensary
Russian Federation

Samara


Competing Interests:

None



D. V. Duplyakov
Samara State Medical University; Polyakov Samara Regional Clinical Cardiology Dispensary
Russian Federation

Samara


Competing Interests:

None



E. V. Savinova
Polyakov Samara Regional Clinical Cardiology Dispensary
Russian Federation

Samara


Competing Interests:

None



References

1. Shioi A, Ikari Y. Plaque calcification during atherosclerosis progression and regression. J Atheroscler Thromb. 2018;25(4):294-303. doi:10.5551/jat.rv17020.

2. Theofilis P, Sagris M, Antonopoulos AS, et al. Non-Invasive Modalities in the Assessment of Vulnerable Coronary Atherosclerotic Plaques. Tomography. 2022;8(4):1742-58. doi:10.3390/tomography8040147.

3. Kochergin NA, Kochergina AM. Potential of optical coherence tomography and intravascular ultrasound in the detection of vulnerable plaques in coronary arteries. Cardiovascular Therapy and Prevention. 2022;21(1):2909. (In Russ.) doi:10.15829/1728-8800-2022-2909.

4. Averkov OV, Duplyakov DV, Gilyarov MYu. Acute myocardial infarction with ST segment elevation electrocardiogram. Clinical guidelines 2020. Russian Society of Cardiology, Association of Cardiovascular Surgeons of Russia. Russian Journal of Cardiology. 2020;25(11):4103. (In Russ.) doi:10.15829/1560-4071-2020-4103.

5. Barbarash OL, Duplyakov DV, Zateishchikov DA, et al. Acute coronary syndrome without ST segment elevation electrocardiogram. Clinical guidelines 2020. Russian Journal of Cardiology. 2021;26(4):4449. (In Russ.) doi:10.15829/1560-4071-2021-4449.

6. Antropova ON, Sukmanova IA, Voloshina UYe. Biomarkers of carotid vulnerable atherosclerotic plaque. Mediсal almanaс. 2023;3(76):119-24. (In Russ.)

7. Cetin M, Ozcan Cetin E, Kalender E, et al. Monocyte to HDL Cholesterol Ratio Predicts Coronary Artery Disease Severity and Future Major Cardiovascular Adverse Events in Acute Coronary Syndrome. Heart Lung Circ. 2016;25(11):1077-86. doi:10.1016/j.hlc.2016.02.023.

8. Manoochehri H, Gheitasi R, Pourjafar M, et al. Investigating the relationship between the severity of coronary artery disease and inflammatory factors of MHR, PHR, NHR, and IL-25. Med J Islam Repub Iran. 2021;35:85. doi:10.47176/mjiri.35.85.

9. Tudurachi B-S, Anghel L, Tudurachi A. Assessment of Inflammatory Hematological Ratios (NLR, PLR, MLR, LMR and Monocyte/HDLCholesterol Ratio) in Acute Myocardial Infarction and Particularities in Young Patients. Int. J. Mol. Sci. 2023;24(18):14378. doi:10.3390/ijms241814378.

10. Kalay N, Dogdu O, Koc F, et al. Hematologic parameters and angiographic progression of coronary atherosclerosis. Angiology. 2012;63(3):213-7. doi:10.1177/0003319711412763.

11. Nilsson L, Wieringa WG, Pundziute G, et al. Neutrophil/Lymphocyte ratio is associated with non-calcified plaque burden in patients with coronary artery disease. PloS One. 2014;9(9):e108183. doi:10.1371/journal.pone.0108183.

12. Zengin A, Karaca M, Arugaslan E, et al. Performance of neutrophil to lymphocyte ratio for the prediction of long-term morbidity and mortality in coronary slow flow phenomenon patients presented with non-ST segment elevation acute coronary syndrome. J.Cardiovasc. Thorac. Res. 2021;13(2):125-30. doi:10.34172/jcvtr.2021.12.

13. Zhang G, Chen M, Yu Z, et al. Relation between neutrophil-to-lymphocyte ratio and severity of coronary artery stenosis. Gene Mol Res. 2014;13(4):9382-9. doi:10.4238/2014. November.11.4.

14. Fan Z, Ji H, Li Y, et al. Relationship between monocyte-to-lymphocyte ratio and coronary plaque vulnerability in patients with stable angina. Biomark Med. 2017;11:979-90. doi:10.2217/bmm-2017-0235.

15. Jiang J, Zeng H, Zhuo Y, et al. Association of Neutrophil to Lymphocyte Ratio With Plaque Rupture in Acute Coronary Syndrome Patients With Only Intermediate Coronary Artery Lesions Assessed by Optical Coherence Tomography. Front Cardiovasc Med. 2022;9:770760. doi:10.3389/fcvm.2022.770760.

16. Wang Y, Peng Z. Prognostic value of platelet/lymphocyte ratio and CAMI-STEMI score for major adverse cardiac events in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention: A prospective observational study. Medicine (Baltimore). 2021;100(33):e26942. doi:10.1097/MD.0000000000026942.

17. Aydın C, Uyan U, Karadeniz M, et al. Role of simple inflammatory parameters in predicting the severity of coronary artery disease. Rev Assoc Med Bras. 2023;69(11):e20230518. doi:10.1590/1806-9282.20230518.

18. Dai K, Li Z, Luo Y, et al. The Predictive Value of the Monocyte-to-Lymphocyte Ratio and Monocyte-to-Haematocrit Ratio for Cardiac Rupture Patients with Acute Myocardial Infarction: A Propensity Score Matching Analysis. Risk Manag. Healthc. Policy. 2022; 15:37-44. doi:10.2147/RMHP.S348894.

19. Arnold von Eckardstein A, Nordestgaard B, Remaley A, Catapano A. High-density lipoprotein revisited: biological functions and clinical relevance. Eur Heart J. 2023; 44(16):1394-407. doi:10.1093/eurheartj/ehac605.

20. Cao J, Li R, He T, et al. Role of combined use of mean platelet volume-to-lymphocyte ratio and monocyte to high-density lipoprotein cholesterol ratio in predicting patients with acute myocardial infarction. J Cardiothorac Surg. 2023;18(1):172. doi:10.1186/s13019-023-02268-4.

21. Rong Y, Ruigang H, Tong W, et al. Correlation between monocyte to highdensity lipoprotein ratio and major adverse cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention. Pak J Med Sci. 2021;37(3):885-9. doi:10.12669/pjms.37.3.3469.

22. Wu T, Zheng Y, Chen Y, et al. Monocyte to high-density lipoprotein cholesterol ratio as long-term prognostic marker in patients with coronary artery disease undergoing percutaneous coronary intervention. Lipids Health Dis. 2019;18(1):180. doi:10.1186/s12944-019-1116-2.


Supplementary files

  • Coronary computed tomography angiography (CCTA) can help to understand the plaque vulne­rability criteria.
  • Combined use of CCTA and various serum and tissue biomarkers may be the key to identifying a vulnerable plaque.
  • Microcalcifications in patients after acute coronary syndrome have a significant relationship with the level of high-density lipoprotein cholesterol (HDL-C), as well as monocyte-to-­HDL-C ratio.

Review

For citations:


Kovalskaya A.N., Bikbaeva G.R., Duplyakov D.V., Savinova E.V. Features of simple inflammation markers in assessing the plaque vulnerability in patients with acute coronary syndrome. Russian Journal of Cardiology. 2025;30(1):5850. (In Russ.) https://doi.org/10.15829/1560-4071-2025-5850. EDN: CPLNDR

Views: 278


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1560-4071 (Print)
ISSN 2618-7620 (Online)